Gabapentin, widely prescribed for chronic pain, may increase dementia risk by up to 40%, according to a new U.S. study. Younger adults (aged 35 to 49) face more than double the dementia risk when taking gabapentin in the long term. The drug alters GABA, a key brain neurotransmitter, potentially leading to cognitive decline. Critics dispute causation but admit concerning correlations. Gabapentin prescriptions remain high despite study warnings, raising concerns about Big Pharma’s safety standards.
Article by Cassie B., republished with permission from Naturalnews.com
A groundbreaking U.S. study reveals that gabapentin, a drug doled out to millions for chronic pain, may increase dementia risk by up to 40%, raising urgent questions about the safety of Big Pharma’s “solutions.”
Trending: Trump posts AI video of Obama’s arrest by FBI agents
Researchers from Case Western Reserve University analyzed
Join the conversation!
Please share your thoughts about this article below. We value your opinions, and would love to see you add to the discussion!